Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
Alhydrogel® adjuvant 2% Phosphate-mediated coanchoring of RBD immunogens and molecular adjuvants to a... 2021 Sci Adv. Rodrigues K.A. et al. DOI: 10.1126/sciadv.abj6538
H4-derived Anti-SARS-CoV2 RBD mAbs, human & mouse isotypes Phosphate-mediated coanchoring of RBD immunogens and molecular adjuvants to a... 2021 Sci Adv. Rodrigues K.A. et al. DOI: 10.1126/sciadv.abj6538
Blasticidin A nuanced role of the small loop of hepatitis B virus small envelope protein ... 2021 J Biomed Sci. Chang C.H. et al. DOI: 10.1186/s12929-021-00780-0
Alhydrogel® adjuvant 2% Protein antigen conjugated with cholesteryl amino-pullulan nanogel shows dela... 2021 Vaccine Long W. et al. DOI: 10.1016/j.vaccine.2021.11.047
Primocin® In-depth comparison of Matrigel dissolving methods on proteomic profiling of ... 2021 Mol Cell Proteomics Wang M. et al. DOI: 10.1016/j.mcpro.2021.100181
Poly(I:C) (HMW) VacciGrade™ SETD5 modulates homeostasis of hematopoietic stem cells by mediating RNA Poly... 2021 Leukemia Li M. et al. DOI: 10.1038/s41375-021-01481-1
Puromycin Therapeutic potential of TRPM8 antagonists in prostate cancer. 2021 Sci Rep Di Donato M. et al. DOI: 10.1038/s41598-021-02675-4
Zeocin® Therapeutic potential of TRPM8 antagonists in prostate cancer. 2021 Sci Rep Di Donato M. et al. DOI: 10.1038/s41598-021-02675-4
G418 (Geneticin) Therapeutic potential of TRPM8 antagonists in prostate cancer. 2021 Sci Rep Di Donato M. et al. DOI: 10.1038/s41598-021-02675-4
LPS-EB (LPS from E. coli O111:B4) Neuropilin-2 regulates airway inflammation in a neutrophilic asthma model. 2021 Immun Inflamm Dis Immormino R.M. et al. DOI: 10.1002/iid3.575
Pam3CSK4 Neuropilin-2 regulates airway inflammation in a neutrophilic asthma model. 2021 Immun Inflamm Dis Immormino R.M. et al. DOI: 10.1002/iid3.575
Alhydrogel® adjuvant 2% A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination. 2021 Virology Hu Z. et al. DOI: 10.1016/j.virol.2021.11.011
Poly(I:C) LMW SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading... 2021 Cell Mol Immunol. Li X. et al. DOI: 10.1038/s41423-021-00807-4
Puromycin MLL1 is regulated by KSHV LANA and is important for virus latency. 2021 Nucleic Acids Res Tan M. et al. DOI: 10.1093/nar/gkab1094
Puromycin Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vi... 2021 EBioMedicine Huang H.C. et al. DOI: 10.1016/j.ebiom.2021.103712
Plasmocure™ - Mycoplasma Elimination Reagent Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Co... 2021 Clin Lab Anal Hayashi K. et al. DOI: 10.1002/jcla.24146
MS4A1 Block-Removed Immunoglobulin Technology to enhance rituximab effector functio... 2021 Oncol Lett Grasso L. et al. DOI: 10.3892/ol.2021.13120
c-di-AMP VacciGrade™ An Established Th2-Oriented Response to an Alum-Adjuvanted SARS-CoV-2 Subunit... 2021 Vaccines (Basel) Cao H. et al. DOI: 10.3390/vaccines9111261
ODN 2395 VacciGrade™ An Established Th2-Oriented Response to an Alum-Adjuvanted SARS-CoV-2 Subunit... 2021 Vaccines (Basel) Cao H. et al. DOI: 10.3390/vaccines9111261
R848 (Resiquimod) Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune re... 2021 Cancer Immunol Immunother Hänel G. et al. DOI: 10.1007/s00262-021-03109-w

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty